When a hospital’s financial gain potentially clashes with patient wellbeing, who draws the ethical line? Host Dr David Rankin is joined by experienced medical administrator Dr Emily Kirkpatrick to explore a complex ethical dilemma facing hospital executives: should a private hospital invest in an expensive spinal surgery robot with questionable clinical benefits? Together, they unpack issues of clinical variation, financial incentives, marketing pressures, and the importance of patient-reported outcomes in delivering truly value-based healthcare.

Disclaimer:

The views, thoughts, and opinions expressed in the following Podcast are the speaker’s own and do not represent the views, thoughts, and opinions of the Royal Australasian College of Medical Administrators (RACMA). The material and information presented here is for general information purposes only, and should not be considered health, legal or financial advice. The cases discussed in the Podcast may be specific to the speaker’s organisation or location, and may not be applicable to other organisations, states, territories or countries. RACMA does not endorse, approve, recommend, or certify any information, product, process, service, or organisation presented or mentioned in this Podcast, and information from this Podcast should not be referenced in any way to imply such approval or endorsement. RACMA will not be held responsible for any losses, damages, or liabilities that may arise from the use of this Podcast. The Podcast may contain descriptions of health incidents that may be graphic and triggering for some people, so listener discretion is advised.

See omnystudio.com/listener for privacy information.